Since November 2020 Fujirebio Europe and CENTOGENE have partnered to leverage LUMIPULSE® G technology for large-scale COVID-19 antigen testing in various German airports, supported by CENTOGENE test centers.
In these airports, sample collection is performed by dedicated CENTOGENE teams, the analysis is performed at CENTOGENE test laboratories using the Lumipulse G SARS-CoV-2 antigen test running on LUMIPULSE G1200 instruments, delivering fast and high-quality results.
In this scenario LUMIPULSE technology is an integrated part of the sophisticated automated CENTOGENE workflow that ensures fast and direct delivery of antigen testing results to travelers on their smartphones or digital devices.
Travelers receive their test results within just one hour after the initial sample collection.
See more about how it works in the video below or read more here about how Fujirebio plays an important role as a healthcare partner, offering various testing solutions that are used across the world today to support fast and trustworthy diagnosis.